Nicholas Galle
About Nicholas Galle
Nicholas Galle is the Manager of Portfolio Management for Peripheral Intervention & Interventional Oncology at Boston Scientific in Maple Grove, MN.
Current Role at Boston Scientific
Nicholas Galle is the Manager of Portfolio Management for Peripheral Intervention & Interventional Oncology at Boston Scientific. Based in Maple Grove, MN, he has been in this role since 2014. In this position, he leads the division R&D annual operating plan process and quarterly forecasts, operationalizes headcount actions and expense tasks to meet division and franchise targets, and implements strategic planning efforts. Nicholas also maintains a 5-year business unit portfolio, establishes program metrics, portfolio cadence maps, franchise dashboards, and project contract scoreboards to evaluate status and progress.
Previous Roles at Boston Scientific
Before his current role, Nicholas Galle served as Principal Portfolio Manager for Cardiac Rhythm Management from 2012 to 2014 in Arden Hills, MN. From 2007 to 2012, he worked as Senior Project Lead/Supervisor for CRM Lead Delivery Systems, also in Arden Hills, MN. His tenure at Boston Scientific demonstrates considerable experience in managing diverse portfolios and leading projects in the medical device industry.
Tenure at Guidant Corp.
Prior to joining Boston Scientific, Nicholas was a Principal Finance Analyst for Patient Management at Guidant Corp. from 2005 to 2007 in Arden Hills, MN. In this role, he was responsible for financial analysis and management, illustrating his expertise in corporate finance within the healthcare sector.
Early Career and Education
Nicholas began his career at Agency Trading Group as Financial and Operations Principal, serving from 2001 to 2005 in Wayzata, MN. He has an MBA with a focus on Marketing from the University of Wisconsin-Madison, where he studied from 1989 to 1991. Additionally, he completed a Graduate Professional Development Program in Corporate Finance at the University of Minnesota-Twin Cities.